Literature DB >> 9618397

Membrane potential-dependent and -independent vasodilation in small pulmonary arteries from chronically hypoxic rats.

R M Priest1, T P Robertson, R M Leach, J P Ward.   

Abstract

Chronic hypoxia is associated with altered pulmonary vasoreactivity, and it has been suggested that an increased response to voltage-dependent vasodilators may relate to enhanced Ca++ entry via voltage-dependent channels, secondary to depolarization. Few studies have been performed on small pulmonary arteries, and it is unknown whether they are depolarized after chronic hypoxia. We examined the resting membrane potential, and the actions of voltage-dependent (verapamil, levcromakalim) and -independent (isoproterenol, forskolin, papaverine) vasodilators in small ( approximately 300 microm internal diameter) pulmonary arteries from chronically hypoxic rats. The resting membrane potential was more positive in arteries after chronic hypoxia (control: -60 +/- 0.5 mV; hypoxic: -54.4 +/- 1.1 mV; P < .01), and this was reflected by a shift to the left of the response curves for K+ and 4-aminopyridine. In arteries constricted with prostaglandin F2alpha the response to verapamil and levcromakalim was increased after chronic hypoxia, although maximum prostaglandin F2alpha-induced tension was unchanged, which implies a reduction in voltage-independent constrictor mechanisms. Although vasorelaxation to isoproterenol was depressed in arteries from hypoxic rats, forskolin-induced relaxation was enhanced substantially, and because the response to the phosphodiesterase inhibitor papaverine was unchanged, we suggest that this reflects an up-regulation of adenylate cyclase. In conclusion, chronic hypoxia resulted in a significant depolarization in small pulmonary arteries, but this may explain only partly the increased efficacy of voltage-dependent vasodilators. Whether the reduction in voltage-independent constrictor mechanisms is related to the apparent up-regulation of adenylate cyclase remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9618397

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  TASK1 (K(2P)3.1) K(+) channel inhibition by endothelin-1 is mediated through Rho kinase-dependent phosphorylation.

Authors:  C Seyler; E Duthil-Straub; E Zitron; J Gierten; E P Scholz; R H A Fink; C A Karle; R Becker; H A Katus; D Thomas
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

2.  Postnatal changes in beta-adrenoceptors in the lung and the effect of hypoxia induced pulmonary hypertension of the newborn.

Authors:  Alison A Hislop; Judith C W Mak; David Kelly; Jayne A Reader; Peter J Barnes; Sheila G Haworth
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

3.  Hypoxia reduces the effect of photoreceptor bleaching.

Authors:  Yun-Bin Lin; Jorn-Hon Liu; Yin Chang
Journal:  J Physiol Sci       Date:  2012-04-28       Impact factor: 2.781

4.  Regional differences in the vasorelaxing effects of testosterone and its 5-reduced metabolites in the canine vasculature.

Authors:  Mercedes Perusquía; Julia Espinoza; Luis M Montaño; John N Stallone
Journal:  Vascul Pharmacol       Date:  2012-02-01       Impact factor: 5.773

5.  Acid-sensing ion channel 1 contributes to pulmonary arterial smooth muscle cell depolarization following hypoxic pulmonary hypertension.

Authors:  Nikki L Jernigan; Jay S Naik; Thomas C Resta
Journal:  J Physiol       Date:  2021-09-25       Impact factor: 5.182

6.  The superoxide dismutase mimetic, tempol, blunts right ventricular hypertrophy in chronic hypoxic rats.

Authors:  Britt Elmedal; Mette Y de Dam; Michael John Mulvany; Ulf Simonsen
Journal:  Br J Pharmacol       Date:  2003-12-01       Impact factor: 8.739

7.  Effects of chronic hypoxia on soluble guanylate cyclase activity in fetal and adult ovine cerebral arteries.

Authors:  William J Pearce; James M Williams; Charles R White; Thomas M Lincoln
Journal:  J Appl Physiol (1985)       Date:  2009-04-30

Review 8.  Hypoxic pulmonary vasoconstriction.

Authors:  J T Sylvester; Larissa A Shimoda; Philip I Aaronson; Jeremy P T Ward
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 46.500

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.